TELIX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHTue, 05 May 2026 09:49:19 +0200https://images.finanzen.net/images/finanzen_net_neu.gifTELIX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netTelix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare ConferenceThu, 08 Jan 2026 12:00:00 +0100https://www.finanzen.net/nachricht/aktien/telix-to-present-pipeline-and-commercial-portfolio-overview-at-j-p-morgan-healthcare-conference-15401671

MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals ...

]]>https://www.finanzen.net/nachricht/aktien/telix-to-present-pipeline-and-commercial-portfolio-overview-at-j-p-morgan-healthcare-conference-15401671DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class ActionsMon, 05 Jan 2026 21:35:00 +0100https://www.finanzen.net/nachricht/aktien/deadline-alert-for-fun-tlx-lrn-prmb-law-offices-of-howard-g-smith-reminds-shareholders-of-opportunity-to-lead-securities-fraud-class-actions-15393473

BENSALEM, Pa., Jan. 5, 2026 /PRNewswire/ -- Law Offices of Howard G. Smith reminds ...

]]>https://www.finanzen.net/nachricht/aktien/deadline-alert-for-fun-tlx-lrn-prmb-law-offices-of-howard-g-smith-reminds-shareholders-of-opportunity-to-lead-securities-fraud-class-actions-15393473TELIX PHARMACEUTICALS (NASDAQ: TLX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 9, 2026Mon, 05 Jan 2026 14:36:00 +0100https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-nasdaq-tlx-class-action-deadline-approaching-berger-montague-advises-investors-to-inquire-about-a-securities-fraud-class-action-by-january-9-2026-15392394

PHILADELPHIA, Jan. 5, 2026 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-nasdaq-tlx-class-action-deadline-approaching-berger-montague-advises-investors-to-inquire-about-a-securities-fraud-class-action-by-january-9-2026-15392394Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitTue, 23 Dec 2025 21:40:00 +0100https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-limited-tlx-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-15377845

LOS ANGELES, Dec. 23, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-limited-tlx-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-15377845Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA ResubmissionsSun, 21 Dec 2025 22:40:00 +0100https://www.finanzen.net/nachricht/aktien/precision-medicine-portfolio-update-illuccix-china-phase-3-study-tlx101-cdx-and-tlx250-cdx-fda-resubmissions-15373385

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...

]]>https://www.finanzen.net/nachricht/aktien/precision-medicine-portfolio-update-illuccix-china-phase-3-study-tlx101-cdx-and-tlx250-cdx-fda-resubmissions-15373385NASDAQ: TLX INVESTOR ALERT: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors of a January 9, 2026 DeadlineMon, 15 Dec 2025 15:41:00 +0100https://www.finanzen.net/nachricht/aktien/nasdaq-tlx-investor-alert-berger-montague-advises-telix-pharmaceuticals-ltd-nasdaq-tlx-investors-of-a-january-9-2026-deadline-15359045

PHILADELPHIA, Dec. 15, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/nasdaq-tlx-investor-alert-berger-montague-advises-telix-pharmaceuticals-ltd-nasdaq-tlx-investors-of-a-january-9-2026-deadline-15359045Telix and Varian Announce Strategic Theranostics-EBRT Clinical CollaborationWed, 10 Dec 2025 20:30:00 +0100https://www.finanzen.net/nachricht/aktien/telix-and-varian-announce-strategic-theranostics-ebrt-clinical-collaboration-15350353

MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Telix ...

]]>https://www.finanzen.net/nachricht/aktien/telix-and-varian-announce-strategic-theranostics-ebrt-clinical-collaboration-15350353CLASS ACTION NOTICE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class ActionTue, 09 Dec 2025 18:35:00 +0100https://www.finanzen.net/nachricht/aktien/class-action-notice-berger-montague-advises-telix-pharmaceuticals-ltd-nasdaq-tlx-investors-to-inquire-about-a-securities-fraud-class-action-15346940

PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/class-action-notice-berger-montague-advises-telix-pharmaceuticals-ltd-nasdaq-tlx-investors-to-inquire-about-a-securities-fraud-class-action-15346940ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans ConfirmedSun, 07 Dec 2025 23:08:00 +0100https://www.finanzen.net/nachricht/aktien/prostact-global-phase-3-update-first-patient-dosed-in-randomized-treatment-expansion-part-1-readout-plans-confirmed-15341101

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...

]]>https://www.finanzen.net/nachricht/aktien/prostact-global-phase-3-update-first-patient-dosed-in-randomized-treatment-expansion-part-1-readout-plans-confirmed-15341101ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action LawsuitTue, 02 Dec 2025 19:25:00 +0100https://www.finanzen.net/nachricht/aktien/attention-nasdaq-tlx-investors-contact-berger-montague-about-a-telix-pharmaceuticals-ltd-class-action-lawsuit-15329551

PHILADELPHIA, Dec. 2, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/attention-nasdaq-tlx-investors-contact-berger-montague-about-a-telix-pharmaceuticals-ltd-class-action-lawsuit-15329551